Karen L. Burton - 02 Jun 2026 Form 4 Insider Report for STERIS plc (STE)

Reporting relationship: Sr. Vice Pres., CFO
Issuer ticker: STE
Reported as of: 02 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 04 Jun 2026, 16:31:51 UTC
Prior SEC filing: 03 Jun 2026
Next SEC filing: 05 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney

Key filing fact

Karen L. Burton filed Form 4 for STERIS plc (STE) on 04 Jun 2026.

Key facts

This page summarizes Karen L. Burton's Form 4 filing for STERIS plc (STE).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2026, 16:31.

Change

Previous filing in this sequence was filed on 03 Jun 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001697095 Primary reporting owner

Burton Karen L

Relationship: Sr. Vice Pres., CFO
Address: 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND
Signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STE transaction

Ordinary Shares

Award

Transaction value
Shares: +5,325
Change %: +65%
Price: $0.000000^*
Shares after: 13,530
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1

STE transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: -66
Change %: -0.49%
Price: $209.76^*
Shares after: 13,464
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +18,564
Change %
Price: $0.000000^*
Shares after: 18,564
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 18,564
Exercise price: $230.74
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

As of June 2, 2026, 10,239 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 651 on June 3, 2026; 306 on June 4, 2026; 783 on October 1, 2026; 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028 and 783 on October 1, 2028 and 1,775 on June 4, 2029.

Footnote F2

66 shares were withheld from the 225 restricted shares that vested on June 2, 2026. These 66 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026.

Footnote F3

This option becomes exercisable as follows: 4,641 on June 2, 2027, 4,641 on June 2, 2028, 4,641 on June 4, 2029 and 4,641 on June 3, 2030.